"The company's consumer healthcare business has been transferred to Cipla Health Ltd, subsidiary of the company, with effect from the close of business hours on February 29, 2016," Cipla said in a filing to BSE.
Earlier in December 2015, Cipla's board had approved the transfer of its consumer healthcare business to Cipla Health Ltd for a total consideration of Rs 16 crore.
Also Read
The transfer of the consumer healthcare business to Cipla Health will enable the Mumbai-based firm to participate in the attractive and growing over-the-counter market.
"This business requires a specialised FMCG kind of focus, and a separate subsidiary would enable the company to attract the right talent and provide the focus and attention required for this business," the company had said.
Shares of Cipla today closed at Rs 517.50 per scrip on BSE, up 0.49% from the previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)